1. Home
  2. FGEN vs BOSC Comparison

FGEN vs BOSC Comparison

Compare FGEN & BOSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • BOSC
  • Stock Information
  • Founded
  • FGEN 1993
  • BOSC 1990
  • Country
  • FGEN United States
  • BOSC Israel
  • Employees
  • FGEN N/A
  • BOSC N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • BOSC Computer Communications Equipment
  • Sector
  • FGEN Health Care
  • BOSC Telecommunications
  • Exchange
  • FGEN Nasdaq
  • BOSC Nasdaq
  • Market Cap
  • FGEN 33.5M
  • BOSC 29.5M
  • IPO Year
  • FGEN 2014
  • BOSC 1996
  • Fundamental
  • Price
  • FGEN $7.18
  • BOSC $4.95
  • Analyst Decision
  • FGEN Strong Buy
  • BOSC
  • Analyst Count
  • FGEN 1
  • BOSC 0
  • Target Price
  • FGEN $250.00
  • BOSC N/A
  • AVG Volume (30 Days)
  • FGEN 42.5K
  • BOSC 121.3K
  • Earning Date
  • FGEN 08-05-2025
  • BOSC 08-21-2025
  • Dividend Yield
  • FGEN N/A
  • BOSC N/A
  • EPS Growth
  • FGEN N/A
  • BOSC 35.10
  • EPS
  • FGEN N/A
  • BOSC 0.49
  • Revenue
  • FGEN $6,996,000.00
  • BOSC $43,688,000.00
  • Revenue This Year
  • FGEN N/A
  • BOSC N/A
  • Revenue Next Year
  • FGEN N/A
  • BOSC N/A
  • P/E Ratio
  • FGEN N/A
  • BOSC $10.24
  • Revenue Growth
  • FGEN N/A
  • BOSC 0.84
  • 52 Week Low
  • FGEN $4.50
  • BOSC $2.50
  • 52 Week High
  • FGEN $30.50
  • BOSC $5.50
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 52.22
  • BOSC 51.29
  • Support Level
  • FGEN $7.04
  • BOSC $4.88
  • Resistance Level
  • FGEN $7.56
  • BOSC $5.10
  • Average True Range (ATR)
  • FGEN 0.57
  • BOSC 0.23
  • MACD
  • FGEN 0.03
  • BOSC -0.03
  • Stochastic Oscillator
  • FGEN 45.20
  • BOSC 37.31

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

Share on Social Networks: